BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Achillion’s ACH-4471 is an Orphan Drug in the U.S. and Europe for PNH

  The EMA Committee for Orphan Medicinal Products also issued a positive opinion on ACH-4471 for orphan status in the European Union for the treatment of PNH.

  November 6, 2017

   · 

  7 min read
• Pharm Country

  ContraVir Pharmaceuticals to Receive Non-Dilutive Funding through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

  As a result, the company expects to receive approximately $1.6 million of net cash proceeds prior to the end of 2017.

  November 6, 2017

   · 

  3 min read
• Business

  CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results

  CombiMatrix reported total revenues for the third quarter of 2017 of $4.0 million, a 23.5% increase from $3.2 million for the third quarter of 2016.

  November 6, 2017

   · 

  16 min read
• Business

  Banner ALZ’s Institute, Novartis, and Amgen Expand Collaboration in Pioneering ALZ’s Prevention Program

  November 6, 2017

   · 

  4 min read
• Business

  Adaptive Biotechnologies Announces a Collaboration with Amgen to Advance Clinical Development of the clonoSEQ Assay in Multiple Myeloma

  Adaptive Biotechnologies announces it has entered into a collaboration agreement with Amgen to utilize Adaptive’s NGS-based clonoSEQ Assay in the Phase 3 CANDOR study.

  November 6, 2017

   · 

  2 min read
• Biohit Oyj B-shares Subscribed With Stock Options I 2013

  A total number of 110 000 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 5 May 2017 and 12 October 2017.

  November 6, 2017

   · 

  1 min read
• Biotech Beach

  New GSK Multi-Country Survey Reveals Need for Improved Awareness Around Long-Term Impact and Appropriate Use of Corticosteroids in SLE Management

  Results from EnABLE highlight an opportunity for increased awareness on appropriate corticosteroid use and a more proactive approach to the management of SLE.

  November 6, 2017

   · 

  5 min read
• Biotech Beach

  Ensysce Biosciences to Present at Human Abuse Liability & Abuse-Deterrent Formulations Conference in Bethesda, Maryland on November 6th and 7th

  The conference will provide information and training to participants on topics such as: preclinical development of abuse-deterrent drugs and delivery mechanisms, clinical trial design, and building strong, reliable networks with every stakeholder throughout the regulatory and market access community.

  November 6, 2017

   · 

  3 min read
• Business

  Soligenix Announces Recent Accomplishments and Third Quarter 2017 Financial Results

  Soligenix announced today its recent accomplishments and financial results for the third quarter ended September 30, 2017.

  November 6, 2017

   · 

  8 min read
• Drug Development

  Novartis Seeks Leadership With Cosentyx Showing No Radiographic Progression in Ankylosing Spondylitis at 4 Years

  The new data also confirm sustained improvement in signs and symptoms in almost 80 percent of patients, while Cosentyx delivers a favorable and consistent safety profile[1].

  November 6, 2017

   · 

  11 min read